Cross Country Healthcare Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cross Country Healthcare Inc's ROI in the first quarter of 2026?
Cross Country Healthcare Inc recorded a cumulative net loss of $-99 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -24.03%.

Within the Services sector 439 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3000 to 3405.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	-13.57 %	-10.18 %	-7.82 %	-8.52 %	-9.83 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	361	371	453	458	467
Return On Investment (TTM)	-24.03 %	-21.7 %	-3.4 %	-1.79 %	-3.73 %
CCRN's Overall Ranking	# 3405	# 3000	# 2443	# 0	# 2021
Seq. Investment Change TTM	-6.1 %	-5.29 %	-1.29 %	-1.55 %	-2.42 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-99	-95	-16	-8	-18

CCRN Company Profile >> Back to CCRN Roi Comparisons >> See Annual CCRN Return On Investment

Return On Investment CCRN's Ranking
Within:	No.
Industry	# 106
Sector	# 440
Overall	# 3405

Return On Investment Statistics
High	Average	Low
38.4 %	-0.3 %	-27.09 %
(Jun 30 2022)		(Sep 30 2014)

Financial Statements
Cross Country Healthcare Inc's I. Quarter Investments	$ 361 Millions	CCRN's Balance sheet
Cross Country Healthcare Inc's I. Quarter Income	$ -4 Millions	Quarterly CCRN's Income Statement
CCRN's Income by Division		See CCRN's Income by Division

CCRN Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	371	469	531	676	533
Y / Y Investment Growth	-20.83 %	-11.66 %	-21.51 %	26.86 %	101.84 %
Net Income in Millions	-95	-15	73	188	132
Y / Y Net Income Growth	-	-	-61.46 %	42.77 %	-
Annual Return On Investment	-25.55 %	-3.1 %	13.69 %	27.87 %	24.76 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Professional Services Industry Roi Trends and Statistics
Services Sector Return On Investment Statistics
Roi Trends for overall market
CCRN's Roi Ratio versus Professional Services Industry, Services Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CCRN's Competitors
Subscribers only: Roi for Cross Country Healthcare Inc's Suppliers
Subscribers only: Return On Investment for CCRN's Customers

Other Ratios
CCRN's Roa	CCRN's Inventory Turnover Ratio	CCRN's Growth Rates	CCRN's Dividend Statistics
	CCRN's Profitability Ratios	CCRN's Asset Turnover Ratio	CCRN's Dividend Growth
CCRN's Roe	CCRN's Valuation Ratios	CCRN's Financial Strength Ratios	CCRN's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Services Sector

ROI

Date modified: 2026-09-26T07:00:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.